Buy Aptose Biosciences Stock | APTO Stock Price & Latest News | Public
APTO

Aptose Biosciences

$0.00 (0.00%)Today

    About APTO

    Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.07
    -0.14
    -0.21
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.17

    Actual EPS
    Q4 2020

    Stats

    Market Cap$552,71M
    Volume20,49k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.25
    1 Year Low$2.43
    Open$6.22
    High$6.32
    Low$6.11

    Buy any stock with any amount of money.

    Download the App
    Download the app